Clinical significance of T cell monitoring during antithymocyte globulin induction in renal transplantation

T CELL monitoring during antithymocyte globulin (ATG) induction therapy has been reported by several investigators to reduce the total amount of the drug given, and therefore the number of complications and cost of treatment. 1 We decided to carry out this investigation in order to compare the effic...

Full description

Saved in:
Bibliographic Details
Published in:Transplantation proceedings 1997-08, Vol.29 (5), p.2330-2331
Main Authors: Thervet, E., Chatenoud, L., Legendre, C., Mamzer-Bruneel, M-F., Kreis, H., Bach, J.F.
Format: Article
Language:English
Subjects:
Antilymphocyte Serum - administration & dosage
Biological and medical sciences
Graft Rejection - immunology
Graft Rejection - prevention & control
Humans
Immunosuppressive Agents - administration & dosage
Kidney Transplantation - immunology
Medical sciences
Monitoring, Immunologic
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the urinary system
T-Lymphocytes - immunology
Transplantation, Homologous
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:T CELL monitoring during antithymocyte globulin (ATG) induction therapy has been reported by several investigators to reduce the total amount of the drug given, and therefore the number of complications and cost of treatment. 1 We decided to carry out this investigation in order to compare the efficacy and the adverse events observed with different ATG regimes and to correlate the T cell subset monitoring with the different clinical events.
ISSN:0041-1345
1873-2623
DOI:10.1016/S0041-1345(97)00388-6